Company Analysis

Scynexis, Inc. (SCYX)

Nasdaq: SCYX · Pharmaceutical Preparations · Jersey City, NJ · filing with the SEC since 2002
Grade5.8
◀ Past 4.4● Present 6.9▶ Future 5.7

Who runs Scynexis, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Angulo Gonzalez David
Chief Executive Officer. First filing Jun 2015, latest Apr 2, 2026, 12 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
18 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Subramanian SanjayChief Financial OfficerSep 2026Sep 11, 2026none
Angulo Gonzalez DavidChief Executive OfficerJun 2015Apr 2, 2026none
Macleod IvorChief Financial OfficerOct 2022Feb 2, 2026none
Sukenick ScottChief Legal OfficerNov 2017Feb 2, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Burke Steven KeithdirectorSep 2026Sep 22, 2026none
Anido ArmandodirectorJan 2019Jun 30, 2026none
Hanham AnndirectorMay 2014Jun 30, 2026none
Hastings David CdirectorSep 2015Jun 30, 2026none
Macdonald GuydirectorDec 2014Jun 30, 2026none
Tinmouth Brian PhilippedirectorDec 2019Jun 30, 2026none
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SCYX · research, not advice